Sanofi Reports Positive Revenue Growth and Focus on Biopharmaceuticals
On February 1, 2024, Sanofi, a renowned French pharmaceutical company, unveiled its fourth-quarter 2022 performance, revealing a 5.2% decline in...
On February 1, 2024, Sanofi, a renowned French pharmaceutical company, unveiled its fourth-quarter 2022 performance, revealing a 5.2% decline in...
On February 1, 2024, Ashland (NYSE: ASH) received an Underweight rating from JP Morgan analyst Jeffrey Zekauskas, who increased the...
IGC Pharma, a leading pharmaceutical company, has recently shared exciting news regarding its drug candidate TGR-63. Groundbreaking preclinical trial data...
On February 1, 2024, Avery Dennison (NYSE:AVY) received positive feedback from JP Morgan analyst Jeffrey Zekaukas. Zekaukas maintained an "Overweight"...
Enterprise Prods Partners (NYSE:EPD) announced its fourth-quarter earnings on February 1, 2024, at 06:00 AM. Here are the important highlights:...
On February 1, 2024, Diana Shipping Inc. proudly announced its latest achievement in the maritime industry. The renowned company has...
On February 1, 2024, Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) successfully completed an underwritten public offering, raising approximately $82.2 million...
Raymond James analyst Buck Horne has expressed his optimism for D.R. Horton by maintaining an Outperform rating on the company....
On February 1, 2024, Adam Samuelson, an analyst at Goldman Sachs, reaffirmed his positive sentiment towards Nutrien (NTR) by maintaining...
Peloton is set to make a significant comeback with the relaunch of its Tread+ on February 1, 2024. This strategic...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com